ABSTRACT
OBJETIVO: Avaliação dos resultados da utilização de enxerto de espessura parcial de esclera autóloga para o tratamento das úlceras esclerais profundas, como complicação tardia da exérese de pterígio associada à betaterapia. MÉTODOS: Foram tratados doze olhos de doze pacientes, nove femininos e três masculinos, com idade variando entre 48 e 82 anos, média 65,2 anos. RESULTADOS: Houve boa integração do enxerto em todos os casos, com resultado funcional e cosmético favorável e sem complicações. CONCLUSÃO: Várias técnicas de enxertia tem sido propostas para o tratamento da úlcera escleral: esclera e dura-máter homólogas, derme, cartilagem auricular e periósteo autólogos. No entanto, o procedimento com esclera autóloga apresenta reais vantagens em relaçâo aos enxertos empregados anteriormente. Não há referências na literatura quanto ao emprego de enxerto de esclera autóloga de espessura parcial para o tratamento da úlcera escleral.
OBJETICVE: The authors describes a surgical technique that utilizes autologus delaminated scleral graft for the management of deep scleral ulcers. METHODS: In this technique that were perfomed in 12 eyes of 12 patients, 9 female, 3 male, age from 48 to 82 years, mean age 65.2 years. RESULTS: Occurred good integration of the grafting in all cases without any complications. CONCLUSION: Many techniques have been proposed for the management of scleral ulcers: sclera and dura-mater, autologus derme, auricular cartilage and autologus periosteum.There is no reference in relation to autologus scleral grafting with partial thickness for the treatment of scleral ulcers, as proposed in this study.
Subject(s)
Humans , Male , Female , Middle Aged , Aged , Aged, 80 and over , Radiation Injuries/surgery , Radiation Injuries/etiology , Sclera/transplantation , Beta Particles/adverse effects , Scleral Diseases/surgery , Scleral Diseases/etiology , Postoperative Complications , Sclera/radiation effects , Surgical Flaps , Beta Particles/therapeutic use , Pterygium/surgery , Pterygium/radiotherapy , AutograftsABSTRACT
Background & objectives: Radioiodine (131I) or radioactive iodine in low doses is used worldwide as the first line of management in the treatment of hyperthyroidism. Information is available on the extent and severity of cell damage after a high dose radioiodine (131I) therapy for thyroid cancer, but information is scanty on its cellular effects, its extent and severity of cell damage after a low dose 131I therapy. The present investigation was aimed to study the cytotoxic effects of a low dose 131I therapy in varying doses as is normally being used in routine clinical practice in the treatment of various forms of hyperthyroidism. Methods: Peripheral blood lymphocytes were analyzed in 32 hyperthyroid patients. All of them received 131I in the form of sodium iodide solution orally. Blood lymphocytes were studied for the presence of chromosomal aberrations (CA) and micro nucleus (MN) using micronucleus assay. Blood samples of these patients were drawn prior to the treatment, on 7 thand 30 thdays after the treatment. Results: The results indicated a positive relationship between 131I dose, CA and MN frequency. A statistically significant increase in CA and MN frequency in day 7 post- therapy and a decrease in mean levels of CA and MN on day 30 post-therapy were observed when compared to pre-therapy. Interpretation & conclusions: This study showed that the cytogenetic damage induced by 131I in low doses i.e., less than 555MBq was minimal and reversible. Patients can be motivated to undertake this safe and easy procedure as a first line of therapy in the treatment of hyperthyroidism.
Subject(s)
Administration, Oral , Adult , Beta Particles/adverse effects , Beta Particles/therapeutic use , Chromosome Aberrations/radiation effects , Humans , Hyperthyroidism/pathology , Hyperthyroidism/radiotherapy , Iodine Radioisotopes/administration & dosage , Iodine Radioisotopes/adverse effects , Iodine Radioisotopes/therapeutic use , Micronuclei, Chromosome-Defective/radiation effects , Micronucleus Tests/methods , Middle Aged , Radiation Dosage , Thyroid Gland/metabolism , Thyroid Gland/radiation effectsABSTRACT
There has been much debate about the use of depleted uranium in the Gulf War and its health effects on United States and European war veterans. However, studies on the impact of this radioactive substance on the residents of the surrounding Gulf region are far from adequate. Depleted uranium introduces large quantities of radioactive material that is hazardous to biological organisms, continues to decay for millennia and is able to travel tens of kilometres in air. If depleted uranium were used in the Gulf War, its impact on the health of people in the area would have been considerable. This review of depleted uranium-its origin, properties, uses and effects on the human environment and health-aims to trigger further research on this subject
Subject(s)
Humans , Alpha Particles/adverse effects , Beta Particles/adverse effects , Environmental Health/statistics & numerical data , Gamma Rays/adverse effects , Military Personnel , Occupational Exposure/adverse effects , Persian Gulf Syndrome/etiology , Radioactive Waste/adverse effects , Radiometry , Armed ConflictsABSTRACT
La amenaza de una guerra o un accidente nuclear nos llena de curiosidad e indiferencia. En general esto se refleja a nivel mundial con muy poca bibliografía disponible que nos dé información sobre estos eventos y las conductas más aconsejadas para su control y tratamiento. Veremos en este trabajo las características de las distintas radiaciones, nociones de lo significativamente importante para el especialista que son los efectos sobre el individuo y los criterios para diagnóstico, pronóstico y tratamiento.
Subject(s)
Humans , Radioactive Hazard Release/mortality , Radioactive Hazard Release/prevention & control , Beta Particles/adverse effects , Gamma Rays/adverse effects , Radiation Injuries/diagnosis , Radiation Injuries/therapy , Neutrons/adverse effects , Alpha Particles/adverse effects , Radiotherapy/adverse effects , Anesthesia , Blindness , Burns , Hepatitis/complications , Mass Casualty Management , Nephritis/complications , Nephritis/mortality , Radiation Pneumonitis/complications , Radiation Pneumonitis , Radiation Pneumonitis/therapy , Pericarditis/complications , Postoperative CareABSTRACT
Apresenta-se um caso de ulceraçäo de esclera como complicaçäo tardia de betaterapia, que se manifestou antes de dois anos após tratamento cirúrgico de pterígio, seguida por irradiaçäo. Faz ainda consideraçöes sobre os outros efeitos indesejáveis da beta-terapia ocular bem como sobre a necessidade de critério quanto à indicaçäo cirúrgica e a dose de radiaçäo